SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-20-025859
Filing Date
2020-09-09
Accepted
2020-09-09 16:16:52
Documents
5
Effectiveness Date
2020-09-09

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea126543-s8_pluristemthera.htm S-8 42966
2 OPINION OF SULLIVAN & WORCESTER LLP ea126543ex5-1_pluristem.htm EX-5.1 9703
3 CONSENT OF KOST FORER GABBAY & KASIERER, A MEMBER OF ERNST & YOUNG GLOBAL ea126543ex23-2_pluristem.htm EX-23.2 3622
4 GRAPHIC ex5-1_001.jpg GRAPHIC 11789
5 GRAPHIC ex5-1_002.jpg GRAPHIC 8539
  Complete submission text file 0001213900-20-025859.txt   85824
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 3508409
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 3508409 972-74-710-7171
PLURISTEM THERAPEUTICS INC (Filer) CIK: 0001158780 (see all company filings)

IRS No.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
Type: S-8 | Act: 33 | File No.: 333-248686 | Film No.: 201166700
SIC: 2836 Biological Products, (No Diagnostic Substances)